Literature DB >> 26893713

Expression and clinical significance of Sirt1 in colorectal cancer.

Deng-Feng Yu1, Su-Juan Jiang2, Zhi-Peng Pan3, Wei-Dong Cheng4, Wen-Jun Zhang4, Xiao-Kun Yao3, Yu-Cheng Li5, Yong-Zhi Lun3.   

Abstract

The objective of the present study was to examine the expression of Silent information regulator 1 (Sirt1) in colorectal cancer and peritumoral normal mucosa tissue, and therefore analyze the role and molecular mechanism of Sirt1 in the pathogenesis of colorectal cancer. Colorectal cancer tissue specimens were employed as the experimental group, and adjacent normal mucosa tissues >5 cm from tumor lesions were used as the control group. The expression of Sirt1 was detected by the immunohistochemical streptavidin peroxidase detection method in paraffin-embedded sections, whilst Sirt1 protein expression was examined by western blot analysis in the fresh tissues. Sirt1 protein was primarily expressed in the nuclei of the tumor cells, and positive staining was brownish-yellow in color. The relative expression quantities of Sirt1 in the peritumoral normal rectal mucosa and rectal carcinoma were 1.15 and 2.62, and the differences between the two groups were statistically significant (P<0.05). The expression level of Sirt1 in colorectal carcinoma was significantly associated with the depth of tumor invasion, differentiation and tumor size (P<0.05). Sirt1 expression was also found to be associated with tumor tissue type, lymph node metastasis, Duke's stage and patient age. These characteristics combined may therefore be used as markers for the early diagnosis of colorectal cancer pathogenesis.

Entities:  

Keywords:  Sirt1; clinical significance; colorectal cancer; expression

Year:  2015        PMID: 26893713      PMCID: PMC4738140          DOI: 10.3892/ol.2015.3982

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  36 in total

Review 1.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer.

Authors:  N A Newman; K L Votanopoulos; J H Stewart; P Shen; E A Levine
Journal:  Minerva Chir       Date:  2012-08       Impact factor: 1.000

Review 2.  Role of gastrin-peptides in Barrett's and colorectal carcinogenesis.

Authors:  Eduardo Chueca; Angel Lanas; Elena Piazuelo
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

Review 3.  Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.

Authors:  Samy A Azer
Journal:  Eur J Gastroenterol Hepatol       Date:  2013-03       Impact factor: 2.566

4.  [A novel histological typing and grading-scale system of colorectal cancer].

Authors:  Jun Yang; Rui Guo; Anjing Kang; Xiaoli Chen; Baoshan Su; Xiaozhong Huang; Yaofeng Jin; Zongfang Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2014-02

5.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Authors:  Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair
Journal:  Nature       Date:  2003-08-24       Impact factor: 49.962

6.  Evidence for a common mechanism of SIRT1 regulation by allosteric activators.

Authors:  Basil P Hubbard; Ana P Gomes; Han Dai; Jun Li; April W Case; Thomas Considine; Thomas V Riera; Jessica E Lee; Sook Yen E; Dudley W Lamming; Bradley L Pentelute; Eli R Schuman; Linda A Stevens; Alvin J Y Ling; Sean M Armour; Shaday Michan; Huizhen Zhao; Yong Jiang; Sharon M Sweitzer; Charles A Blum; Jeremy S Disch; Pui Yee Ng; Konrad T Howitz; Anabela P Rolo; Yoshitomo Hamuro; Joel Moss; Robert B Perni; James L Ellis; George P Vlasuk; David A Sinclair
Journal:  Science       Date:  2013-03-08       Impact factor: 47.728

7.  Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma.

Authors:  Xingjun Yao; Gang Zhao; Hongfa Yang; Xinyu Hong; Li Bie; Guojin Liu
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-07       Impact factor: 4.553

Review 8.  The Sir2 family of protein deacetylases.

Authors:  Gil Blander; Leonard Guarente
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

9.  SIRT1 is significantly elevated in mouse and human prostate cancer.

Authors:  Derek M Huffman; William E Grizzle; Marcas M Bamman; Jeong-su Kim; Isam A Eltoum; Ada Elgavish; Tim R Nagy
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

10.  Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer.

Authors:  Lydia Kriegl; Michael Vieth; Thomas Kirchner; Antje Menssen
Journal:  Oncotarget       Date:  2012-10
View more
  11 in total

Review 1.  Association of sirtuins (SIRT1-7) with lung and intestinal diseases.

Authors:  Yuhan Chen; Di Zhou; Yuan Feng; Bingxin Li; Yong Cui; Gang Chen; Ning Li
Journal:  Mol Cell Biochem       Date:  2022-05-20       Impact factor: 3.396

2.  The anti-tumour effect of induced pluripotent stem cells against submandibular gland carcinoma in rats is achieved via modulation of the apoptotic response and the expression of Sirt-1, TGF-β, and MALAT-1 in cancer cells.

Authors:  Eman Mohamed Faruk; Dina Sabry; Ahmed A Morsi; Yasmine Alaa El-Din; Neama M Taha; Engy Medhat
Journal:  Mol Cell Biochem       Date:  2021-09-17       Impact factor: 3.396

Review 3.  Emerging roles for lncRNA-NEAT1 in colorectal cancer.

Authors:  Shirin Azizidoost; Farhoodeh Ghaedrahmati; Omid Anbiyaee; Riyadh Ahmad Ali; Maryam Cheraghzadeh; Maryam Farzaneh
Journal:  Cancer Cell Int       Date:  2022-06-08       Impact factor: 6.429

Review 4.  Role of Post-translational Modification of Silent Mating Type Information Regulator 2 Homolog 1 in Cancer and Other Disorders.

Authors:  Yeon-Hwa Lee; Su-Jung Kim; Young-Joon Surh
Journal:  J Cancer Prev       Date:  2022-09-30

5.  Association between the methylation status of PCDH17 and the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer.

Authors:  De-Di Kong; Rong-Zhan Fu; Liang Li; Wei Wang; Shi-Bing Wang
Journal:  Oncol Lett       Date:  2020-06-16       Impact factor: 2.967

6.  Evodiamine inhibits migration and invasion by Sirt1-mediated post-translational modulations in colorectal cancer.

Authors:  Peng Zhou; Xiao-Peng Li; Rong Jiang; Yi Chen; Xiao-Ting Lv; Xing-Xian Guo; Kuan Tian; De-Zhi Yuan; Yan-Wei Lv; Jian-Hua Ran; Jing Li; Di-Long Chen
Journal:  Anticancer Drugs       Date:  2019-07       Impact factor: 2.248

Review 7.  Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment.

Authors:  Oana-Maria Thoma; Markus F Neurath; Maximilian J Waldner
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

Review 8.  Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer.

Authors:  Rosario Avolio; Danilo Swann Matassa; Daniela Criscuolo; Matteo Landriscina; Franca Esposito
Journal:  Biomolecules       Date:  2020-01-14

9.  Liquid Chromatography-Mass Spectrometry-Based Plasma Metabolomics Study of the Effects of Moxibustion with Seed-Sized Moxa Cone on Hyperlipidemia.

Authors:  Qinghua Shao; Jie Cheng; Yi Li; Guangxia Ni
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-22       Impact factor: 2.629

10.  9-ING-41, a Small Molecule Inhibitor of GSK-3β, Potentiates the Effects of Chemotherapy on Colorectal Cancer Cells.

Authors:  Andrey Poloznikov; Sergey Nikulin; Larisa Bolotina; Andrei Kachmazov; Maria Raigorodskaya; Anna Kudryavtseva; Ildar Bakhtogarimov; Sergey Rodin; Irina Gaisina; Maxim Topchiy; Andrey Asachenko; Victor Novosad; Alexander Tonevitsky; Boris Alekseev
Journal:  Front Pharmacol       Date:  2021-12-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.